N@N

STEL, PYV, AUXL, CCBG, SNTS, LSE Are Seasonally Ripe To Go Down In the Next Five Weeks

April 16, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of STELLARONE CORP (NASDAQ:STEL), Merrill Lynch Depositor Inc. PPLUS Floating Rate Trust Certificates Series JPM (NYSE:PYV), AUXILIUM PHARMACEUTICALS INC (NASDAQ:AUXL), CAPITAL CITY BANK GROUP INC (NASDAQ:CCBG), SANTARUS INC (NASDAQ:SNTS), CAPLEASE INC (NYSE:LSE) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  STEL    STELLARONE CORP                  -8.85%           90.00% (9 of 10)     Friday, May 18th 2012
  PYV     Merrill Lynch Depositor Inc. PPLUS Floating Rate Trust Certificates Series JPM  -0.57%           85.71% (6 of 7)      Thursday, April 19th 2012
  AUXL    AUXILIUM PHARMACEUTICALS INC     -8.94%           85.71% (6 of 7)      Monday, May 7th 2012
  CCBG    CAPITAL CITY BANK GROUP INC      -6.28%           91.67% (11 of 12)    Monday, May 14th 2012
  SNTS    SANTARUS INC                     -7.11%           87.50% (7 of 8)      Friday, May 4th 2012
  LSE     CAPLEASE INC                     -4.16%           87.50% (7 of 8)      Monday, May 21st 2012

STELLARONE CORP (NASDAQ:STEL) - StellarOne Corporation operates as the bank holding company for StellarOne Bank that provides various retail and small business banking, commercial banking, consumer lending, mortgage banking, and wealth management services to individuals, and small and middle-market businesses in Virginia. It generates various deposit products, including demand and time deposit accounts, money market accounts, checking accounts, certificates of deposit, and savings accounts. The companys loan portfolio comprises consumer and commercial real estate loans, real estate and construction loans, commercial lines of credit, commercial term loans, home equity loans, consumer loans, and commercial, financial, and agricultural loans. It also provides credit cards, automated teller machine networks, and telephone and Internet banking, and online bill payment services. In addition, the company provides various wealth management and personal trust services, including estate administration and employee benefit plan administration, and planning specifically addressing the investment and financial management needs of its customers. As of December 31, 2009, StellarOne Corporation operated 56 financial centers, 1 loan production office, and approximately 60 automated teller machines in New River Valley, Roanoke Valley, Shenandoah Valley, and central and north central Virginia. The company was formerly known as Virginia Financial Group, Inc. and changed its name to StellarOne Corporation in February 2008. StellarOne Corporation was founded in 1911 and is headquartered in Charlottesville, Virginia.

Merrill Lynch Depositor Inc. PPLUS Floating Rate Trust Certificates Series JPM (NYSE:PYV) - Merrill Lynch Depositor Inc. PPLUS Floating Rate Trust Certificates Series JPM

AUXILIUM PHARMACEUTICALS INC (NASDAQ:AUXL) - Auxilium Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company primarily in the United States. It focuses on developing and marketing products to urologists, endocrinologists, primary care physicians, hand surgeons, and rheumatologists, as well as to orthopedic, general, and plastic surgeons. The company markets XIAFLEX (collagenase clostridium histolyticum), an injectable collagenase enzyme for the treatment of adult Dupuytrens contracture; and Testim, a topical 1% testosterone gel for the treatment of hypogonadism. The companys clinical development products include XIAFLEX that is in Phase III clinical trials for the treatment of Peyronies disease, as well as in Phase II clinical trials for the treatment of Adhesive Capsulitis. In addition, it has rights to develop other products for the treatment of pain, urologic disease, and hormone replacement using its transmucosal film delivery system. The company has a strategic alliance with Asahi Kasei Pharma Corporation for the development, commercialization, and supply of XIAFLEX, a biologic for the treatment of Dupuytrens contracture and Peyronies disease. Auxilium Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Malvern, Pennsylvania.

CAPITAL CITY BANK GROUP INC (NASDAQ:CCBG) - Capital City Bank Group, Inc. operates as the holding company for Capital City Bank that provides commercial and retail banking products and services in Florida, Georgia, and Alabama. Its deposit products include NOW accounts, money market accounts, checking and savings accounts, and time deposits. The company offers financing for commercial business properties, equipment, inventories, and accounts receivable, as well as commercial leasing and letters of credit; commercial and residential real estate lending; tax-exempt loans, lines of credit, and term loans; and retail credit products, including personal loans, automobile loans, boat/RV loans, home equity loans, and credit card programs. In addition, it provides automated teller machines, debit/credit cards, night deposit, safe deposit facilities, PC/Internet banking, and mobile banking services. Further, the company offers asset management, trust, mortgage banking, merchant credit card transaction processing, bank cards, data processing, and securities brokerage services comprising retail securities products, including U.S. government bonds, tax-free municipal bonds, stocks, mutual funds, unit investment trusts, annuities, life insurance, and long-term health care. It serves individuals, corporations, and other business clients, including commercial developers and investors, residential builders and developers, community developers, state and local governments, public schools and colleges, charities, and membership and not-for-profit associations. As of February 27, 2010, the company had 70 banking locations. Capital City Bank Group was founded in 1982 and is headquartered in Tallahassee, Florida.

SANTARUS INC (NASDAQ:SNTS) - Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. The company commercializes CYCLOSET (bromocriptine mesylate) tablets, and focuses to commercialize GLUMETZA (metformin hydrochloride extended release tablets) that are indicated as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes. It also has a development pipeline with three late-stage product candidates in Phase III clinical programs, including ULTESA (budesonide MMX) for induction of remission of active ulcerative colitis, rifamycin SV MMX for treatment of travelers diarrhea, and RHUCIN (recombinant human C1 inhibitor) for the treatment of acute attacks of hereditary angioedema. In addition, Santarus plans to initiate a Phase I clinical study for SAN-300, an anti-VLA-1 antibody development compound that it expects to develop for the treatment of rheumatoid arthritis. The company was founded in 1996 and is based in San Diego, California.

CAPLEASE INC (NYSE:LSE) - CapLease, Inc. operates as a real estate investment trust (REIT), focused on financing and investing in commercial real estate that is net leased primarily to single tenants with investment grade or near investment grade credit ratings. It provides private and corporate owners of net lease real estate with equity, debt, and mezzanine financing options. The company is organized to qualify as a REIT for federal income tax purposes and accordingly it distributes at least 90% of its taxable income to its stockholders. Capital Lease is based in New York City.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources

---